Rovi Pharmaceuticals Laboratories
Quick facts
Marketed products
Phase 3 pipeline
- Placebo of Risperidone ISM · Psychiatry
This is a placebo control formulation used in clinical trials to compare against the active Risperidone ISM (intramuscular sustained-release) antipsychotic.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: